Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Acadia, Amgen, Arbor, Astrazeneca, Daiichi, Eli Lilly, Everest, Incyte, Johnson, Maat, Omeros, Pharmaessentia, Replimune, Xspray.